Spinal Cord Stimulation Devices Market to Reach $4.8 Billion, Globally, by 2032 at 8.4% CAGR: Allied Market Research

News provided by

Jun 15, 2023, 10:45 ET

PORTLAND, Ore., June 15, 2023 /PRNewswire/ -- Allied Market Research published a report titled, "Spinal Cord Stimulation Devices Market by Product (Rechargeable Devices and Non-rechargeable Devices), Indication (Failed Back Surgery Syndrome, Complex Regional Pain Syndrome, Degenerative Disc Disease, Painful Diabetic Neuropathy, and Others), and End User (Hospitals, Ambulatory Surgical Centres, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032." According to the report, the global spinal cord stimulation devices market was valued at $2.1 billion in 2022 and is estimated to reach $4.8 billion by 2032, exhibiting a CAGR of 8.4% from 2023 to 2032.

Download Sample Copy- https://www.alliedmarketresearch.com/request-sample/3792

Prime Determinants of Growth:

The spinal cord stimulation devices market is experiencing growth due to several factors, such as an increase in the prevalence of chronic pain conditions, technological advancements in spinal cord stimulation devices, and the availability of medical reimbursement schemes. However, the high cost and side effects of spinal cord stimulation devices and the availability of alternative treatment options for chronic pain conditions are the factors hampering the market's growth. On the contrary, the growth opportunities in emerging markets are expected to offer lucrative opportunities for expansion of the spinal cord stimulation devices market during the forecast period.

Report Coverage & Details:

Report Coverage	Details
Forecast Period	2023–2032
Base Year	2022
Market Size in 2022	$2.1 Billion
Market Size in 2032	$4.8 Billion
CAGR	8.4 %
No. of Pages in Report	258
Segments covered	Product, Indication, End User, and Region
Drivers	An increase in the prevalence of chronic pain conditions Technological advancements in spinal cord stimulation devices The availability of medical reimbursement schemes
Opportunities	Growth opportunities in emerging markets
Restraints	The high cost and side effects of spinal cord stimulation devices Availability of alternative treatment options

Covid-19 Scenario:

The pandemic led to delays in diagnosis and treatment for chronic pain conditions as healthcare systems shifted their resources to COVID-19 treatment.
Furthermore, the closure of hospitals and clinics for surgical procedures during lockdowns resulted in a decline in patient visits and elective surgeries, including spinal cord stimulator implantation. This had resulted in a decline in demand for spinal cord stimulation devices as many patients postponed their treatments.
However, the situation has gradually become normal with increasing funding for research and development activities, with governments and private investors recognizing the importance of developing new and innovative medical devices to address chronic pain management.

Procure Complete Report at 20% Discount (258 Pages PDF with Insights, Charts, Tables, and Figures)
https://www.alliedmarketresearch.com/checkout-final/spinal-cord-stimulation-devices-market

The rechargeable devices segment to maintain its leadership status throughout the forecast period:

Based on product, the rechargeable devices segment held the largest share in 2022, accounting for more than two-thirds of the global spinal cord stimulation devices market revenue and is projected to maintain its leadership status throughout the forecast period. The same segment would display the highest CAGR of 8.6% during the forecast period. owing to several advantages they offer over non-rechargeable devices, such as longer battery life, higher flexibility in programming, and the ability to adjust the stimulation settings according to the patient's needs.

The failed back surgery syndrome segment is anticipated to maintain its dominance throughout the forecast period:

Based on indication, the failed back surgery syndrome segment held the largest share in 2022, contributing to nearly two-fifths of the global spinal cord stimulation devices market revenue, and is anticipated to maintain its dominance throughout the forecast period. Due to an increase in spinal surgeries, more people are turning to spinal cord stimulation therapy, which has been shown to be successful in treating failed back surgery syndrome. However, degenerative disk disease segment is projected to register highest CAGR of 8.9% from 2023 to 2032. Due to an increase in the number of patients with degenerative disk disease and the use of spinal cord stimulation therapy to treat chronic pain.

The hospitals segment to maintain its lead position during the forecast period

Based on end user, the hospitals segment accounted for the largest share in 2022, accounting for more than three-fifth of the global spinal cord stimulation devices market revenue, and is projected to maintain its lead position during the forecast period. The same segment would portray the highest CAGR of 8.6% during the forecast period. Due to the availability and access to specialized healthcare professionals, advanced medical technologies and infrastructure, and strong relationships with insurance providers, resulting in the adoption of spinal cord stimulation therapy.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/3792

North America to maintain its dominance by 2032:

Based on region, North America held the highest market share in terms of revenue in 2022, accounting for more than two-thirds of the global spinal cord stimulation devices market revenue, and it is likely to maintain its dominance by 2032. owing to the high prevalence of chronic pain conditions, the availability of advanced healthcare facilities, and the presence of major players offering spinal cord stimulation devices. In addition, favorable reimbursement policies in healthcare systems and a rise in the geriatric population are expected to propel market expansion. However, the Asia-Pacific region is expected to witness the fastest CAGR of 9.5% from 2023 to 2032. owing to a rise in the number of cases of chronic pain conditions, an increase in awareness regarding available spinal cord stimulation treatment devices, and a surge in investments for the development of effective spinal cord stimulation devices for chronic pain.

Leading Market Players:

Saluda Medical Pty Ltd.
Nevro Corporation
BIOTRONIK SE & Co. KG
Abbott Laboratories
Teliatry, Inc.
Nalu Medical, Inc.
Boston Scientific Corporation
GIMER MEDICAL
Beijing PINS Medical Co., Ltd.
Medtronic plc

The report provides a detailed analysis of these key players in the global spinal cord stimulation devices market. These players have adopted different strategies, such as acquisition, product launch, product approval, and expansion, to increase their market share and maintain dominant positions in different regions. The report is valuable in highlighting business performance, operating segments, product portfolios, and strategic moves of market players to showcase the competitive scenario.

Trending Reports in Healthcare Industry:

VR In Healthcare Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Mobile Gamma Cameras Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

Pharmacogenomics Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Predictive Analytics in Healthcare Market Global Opportunity Analysis and Industry Forecast, 2021–2030

Dental Equipment Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com